Newly discovered innate response activator B cells: Crucial responders against microbial sepsis

Expert Review of Clinical Immunology

Volumn 8, Issue 5, 2012, Pages 405-407

  Robbins, Clinton S ^a   Swirski, Filip K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

B cells; B lymphocytes; granulocyte macrophage colony stimulating factor; infection; innate immunity; sepsis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; NANOMATERIAL; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CELL POPULATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INNATE RESPONSE ACTIVATOR B CELL; NONHUMAN; REVIEW; SEPSIS; SPLEEN;

ANIMALS; B-LYMPHOCYTES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; SEPSIS;

EID: 84865044790     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.32     Document Type: Review

References (15)

1. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8(10), 776-787 (2008
2. Boomer JS, To K, Chang KC et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23), 2594-2605 (2011
3. Rauch PJ, Chudnovskiy A, Robbins CS et al. Innate response activator B cells protect against microbial sepsis. Science 335(6068), 597-601 (2012
4. Basu S, Dunn AR, Marino MW et al. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 159(3), 1412-1417 (1997
5. Spight D, Trapnell B, Zhao B, Berclaz P, Shanley TP. Granulocyte- macrophage colony-stimulating factor-dependent peritoneal macrophage responses determine survival in experimentally induced peritonitis and sepsis in mice. Shock 30(4), 434-442 (2008
6. Gennari R, Alexander JW, Gianotti L, Eaves-Pyles T, Hartmann S. Granulocyte macrophage colony-stimulating factor improves survival in two models of gutderived sepsis by improving gut barrier function and modulating bacterial clearance. Ann. Surg. 220(1), 68-76 (1994
7. Carr R, Brocklehurst P, Doré CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): A single-blind, multicentre, randomised controlled trial. Lancet 373(9659), 226-233 (2009
8. Bo L, Wang F, Zhu J, Li J, Deng X. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: A meta-analysis. Crit. Care 15(1), R58 (2011
9. Metcalf D, Nicola NA, Mifsud S, Di Rago L. Receptor clearance obscures the magnitude of granulocyte-macrophage colony-stimulating factor responses in mice to endotoxin or local infections. Blood 93(5), 1579-1585 (1999
10. Fleischmann J, Golde DW, Weisbart RH, Gasson JC. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68(3), 708-711 (1986
11. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188(12), 2381-2386 (1998
12. Ghosh K, Kanapathipillai M, Korin N, McCarthy JR, Ingber DE. Polymeric nanomaterials for islet targeting and immunotherapeutic delivery. Nano Lett. 12(1), 203-208 (2012
13. Neves P, Lampropoulou V, Calderon-Gomez E et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33(5), 777-790 (2010
14. Kelly-Scumpia KM, Scumpia PO, Weinstein JS et al. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208(8), 1673-1682 (2011
15. Fritz JH, Rojas OL, Simard N et al. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature 481(7380), 199-203 (2012